Phase II study of nab-paclitaxel combined with S-1 in patients with early breast cancer:A multicenter clinical trial
Not Applicable
- Conditions
- early breast cancer
- Registration Number
- JPRN-UMIN000027216
- Lead Sponsor
- The University of Tokushima Graduate School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
(1)DCIS or breast cancer wiht micro invasion. (2)Patients with contraindication for any agents necessary in the planned treatment (3)Male (4)Women who are pregnant, lactating or with childbearing potential. (5)Patients with a history of chemotherapy, endocrinetherapy or radiotherapy. (6)Multiple primary cancer. (7)Serious complications(diabetes infection or mental disorder) (8)Serious complications with cardiac function (9)Patients with serious edema (10)Hypersensitivity to any agents necessary in the planned treatment. (11)Ineligible based on decision of a investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pathological complete response rate (ypT0/is ypN0)
- Secondary Outcome Measures
Name Time Method